Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_assertion type Assertion NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_head.
- NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_assertion description "[KRAS mutation analysis was performed by direct genomic sequencing and revealed a KRAS wildtype in 98.5% except of one adenoid cystic carcinoma with a GGT-GAT transition at codon 12 (Gly12Asp).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_provenance.
- NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_assertion evidence source_evidence_literature NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_provenance.
- NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_assertion SIO_000772 19362042 NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_provenance.
- NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_assertion wasDerivedFrom befree-20140225 NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_provenance.
- NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_assertion wasGeneratedBy ECO_0000203 NP593307.RAlZeLklfIw4jVLW9F2UH39AgUTHPxn8zEoi8glDqzyLU130_provenance.